POXEL SA: Laure-Hélène Mercier Co-Opted as Chair of the Board of Directors of Poxel
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Thu, 3 September 2026
What it is about
Sumitomo PharmaYves DecadtMartin Alexandre MassiasSteigende NachfrageNicolas TroucheSophie Jacq LapointeUniversity Of AixFranceBoston, Massachusetts, United StatesAusbau, Brandenburg, GermanyTokyo, Tokyo, JapanIranJapan
Who published it, and when
How it spread - 1 original report
Thu, 3 September 2026
1 report- finanznachrichten.de19:18first to report
Regulatory News: POXEL SA (Euronext: POXEL FR0012432516), a clinical-stage biopharmaceutical company that has developed innovative treatments for serious chronic diseases with metabolic pathophysiology